Intellectual and Developmental Disabilities Research Center

Members

O’Connor, Mary

Research

Association between prenatal alcohol exposure and child socio-emotional development

Appointments

  • Director, UCLA Fetal Alcohol Spectrum Disorders Clinic
  • Professor, Psychiatry and Biobehavioral Sciences
  • Program Director, ABC Child Partial Outpatient Program
  • Training Director, Tarjan Center for Developmental Disabilities

Biography

Dr. O’Connor’s current work examines psychosocial and psychiatric risk due to prenatal alcohol exposure. Dr. O’Connor has conducted research on the prevention of alcohol consumption in pregnant women, intervention with children with prenatal alcohol exposure, and medical and allied health education on prevention, diagnosis and treatment.

All of her work has focused on collaborative national initiatives with the long-term goal of developing best practice models to be disseminated on local, state, and national levels.

The overarching emphasis of Dr. O’Connor’s research career has been the development, evaluation, and dissemination of empirically supported assessment and treatment methods for high-risk children.

Publications

  1. Voulgarelis, D, Forment, JV, Herencia Ropero, A, Polychronopoulos, D, Cohen-Setton, J, Bender, A et al.. Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers. NPJ Precis Oncol. 2024;8 (1):266. doi: 10.1038/s41698-024-00702-x. PubMed PMID:39558144 PubMed Central PMC11574300.
  2. O'Connor, MJ, Huffman, KN, Ho, K, Marzouk, S, Casas Fuentes, RJ, Zhang, KL et al.. Negative Pressure Wound Therapy with Instillation for Periprosthetic Infection after Breast Reconstruction: A Systematic Review. Plast Reconstr Surg Glob Open. 2024;12 (11):e6267. doi: 10.1097/GOX.0000000000006267. PubMed PMID:39507314 PubMed Central PMC11537567.
  3. Hamilton, EP, Falchook, GS, Wang, JS, Fu, S, Oza, AM, Imedio, ER et al.. Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial. Target Oncol. 2024;19 (6):879-892. doi: 10.1007/s11523-024-01102-8. PubMed PMID:39487373 PubMed Central PMC11557630.
  4. Moumen, A, Masterson, P, O'Connor, MJ, Jackson, SP. Retraction notice to: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage. Cell. 2024;187 (22):6413. doi: 10.1016/j.cell.2024.10.008. PubMed PMID:39389056 .
  5. Hakimi, M, Kamsheh, AM, O'Connor, MJ, Loscalzo, S. Case 3: Shock after Gluteal Abscess Incision and Drainage in a 15-month-old Girl. Pediatr Rev. 2024;45 (10):1-5. doi: 10.1542/pir.2023-006019. PubMed PMID:39349859 .
Search PubMed